Impacts of antipsychotic medication prescribing practices in critically ill adult patients on health resource utilization and new psychoactive medication prescriptions

被引:2
|
作者
Jaworska, Natalia [1 ,2 ]
Soo, Andrea [1 ]
Stelfox, Henry T. [1 ,2 ,3 ,4 ]
Burry, Lisa D. [5 ,6 ]
Fiest, Kirsten M. [1 ,2 ,3 ,4 ,7 ,8 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada
[2] Alberta Hlth Serv, Calgary, AB, Canada
[3] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada
[4] Univ Calgary, OBrien Inst Publ Hlth, Leslie Dan Fac Pharm, Cumming Sch Med, Calgary, AB, Canada
[5] Univ Toronto, Mt Sinai Hosp, Dept Pharm, Toronto, ON, Canada
[6] Univ Toronto, Mt Sinai Hosp, Dept Med, Toronto, ON, Canada
[7] Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada
[8] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada
来源
PLOS ONE | 2023年 / 18卷 / 06期
关键词
INTENSIVE-CARE-UNIT; DELIRIUM; ICU; SLEEP; HALOPERIDOL; GUIDELINES; MANAGEMENT; DURATION; FRAILTY;
D O I
10.1371/journal.pone.0287929
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundAntipsychotic medications are commonly prescribed to critically ill adult patients and initiation of new antipsychotic prescriptions in the intensive care unit (ICU) increases the proportion of patients discharged home on antipsychotics. Critically ill adult patients are also frequently exposed to multiple psychoactive medications during ICU admission and hospitalization including benzodiazepines and opioid medications which may increase the risk of psychoactive polypharmacy following hospital discharge. The associated impact on health resource utilization and risk of new benzodiazepine and opioid prescriptions is unknown. Research questionWhat is the burden of health resource utilization and odds of new prescriptions of benzodiazepines and opioids up to 1-year post-hospital discharge in critically ill patients with new antipsychotic prescriptions at hospital discharge? Study design & methodsWe completed a multi-center, propensity-score matched retrospective cohort study of critically ill adult patients. The primary exposure was administration of & GE;1 dose of an antipsychotic while the patient was admitted in the ICU and ward with continuation at hospital discharge and a filled outpatient prescription within 1-year following hospital discharge. The control group was defined as no doses of antipsychotics administered in the ICU and hospital ward and no filled outpatient prescriptions for antipsychotics within 1-year following hospital discharge. The primary outcome was health resource utilization (72-hour ICU readmission, 30-day hospital readmission, 30-day emergency room visitation, 30-day mortality). Secondary outcomes were administration of benzodiazepines and/or opioids in-hospital and following hospital discharge in patients receiving antipsychotics. Results1,388 propensity-score matched patients were included who did and did not receive antipsychotics in ICU and survived to hospital discharge. New antipsychotic prescriptions were not associated with increased health resource utilization or 30-day mortality following hospital discharge. There was increased odds of new prescriptions of benzodiazepines (adjusted odds ratio [aOR] 1.61 [95%CI 1.19-2.19]) and opioids (aOR 1.82 [95%CI 1.38-2.40]) up to 1-year following hospital discharge in patients continuing antipsychotics at hospital discharge. InterpretationNew antipsychotic prescriptions at hospital discharge are significantly associated with additional prescriptions of benzodiazepines and opioids in-hospital and up to 1-year following hospital discharge.
引用
收藏
页数:15
相关论文
共 45 条
  • [41] Reductions in acute medication use, migraine-related health care resource utilization, and costs for patients initiating fremanezumab: Results of a long-term US claims database analysis
    Krasenbaum, L. J.
    Driessen, M. T.
    Campos, Ramirez V.
    Tian, M.
    Seminerio, M. J.
    Carr, K.
    DiEgidio, R.
    HEADACHE, 2022, 62 : 83 - 84
  • [42] EFFECTS OF GALCANEZUMAB ON ACUTE MEDICATION USE AND HEALTH CARE RESOURCE UTILIZATION IN PATIENTS WITH TREATMENT-RESISTANT MIGRAINE: RESULTS FROM A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL (CONQUER)
    Ford, Janet
    Gomez, Julio Pascual
    Stroud, Chad
    Rettiganti, Mallikarjuna
    Estemalik, Emad
    Day, Kathleen
    Ambrosini, Anna
    CEPHALALGIA, 2020, 40 : 45 - 46
  • [43] MEDICATION ADHERENCE AND CARDIOVASCULAR DISEASE-RELATED HEALTH CARE RESOURCE UTILIZATION AMONG PATIENTS TREATED WITH FIXED DOSE COMBINATION VERSUS MULTI-PILL COMBINATION THERAPIES AMONG PATIENTS WITH DYSLIPIDEMIA IN A MANAGED CARE POPULATION
    Balu, S.
    Simko, R. J.
    Webb, S. F.
    Quimbo, R.
    Cziraky, M. J.
    VALUE IN HEALTH, 2009, 12 (03) : A156 - A156
  • [44] Galcanezumab Significantly Reduced Health Care Resource Utilization and Acute Medication Use in Patients with Chronic Migraine: Findings from a Phase 3, Randomized, Double-Blind, Placebo-Controlled and Open-Label Extension
    Shivang, Joshi
    Tobin, Joshua
    Ford, Janet
    Nichols, Russell
    Foster, Shonda
    Ruff, Dustin
    Detke, Holland
    Aurora, Sheena
    NEUROLOGY, 2019, 92 (15)
  • [45] A Randomized Controlled Trial of Electronic Medication Monitoring (EMM), Patient Mobile App and Health Care Provider Feedback compared to EMM alone on Inhaled Corticosteroids (ICS) and Short Acting Beta2 Agonists (SABA) Utilization and Asthma Control in Adult Patients with Uncontrolled Asthma
    Mosnaim, Giselle
    Gonzalez, Candy
    Adams, Brittney
    Zhu, Linda
    Quan, Priscillia
    Olive, Naomi BenIsrael
    Shalowitz, Madeleine
    Gondalia, Rahul
    Kaye, Leanne
    Stempel, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB58 - AB58